Hemostat Market Analysis and Forecast to 2032: By Product Type (Active Hemostats, Passive/Mechanical Hemostats {Oxidized Regenerated Cellulose-Based Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, and Polysaccharide Spheres Hemostats}, and Flowable Hemostats), Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others), End-use (Ambulatory Surgical Centers, Hospitals, Clinics, Community Healthcare), and Region

The Hemostats Market size was USD 3.4 Billion in 2022 and is anticipated to reach USD 5.9 Billion in 2032, growing at a rate of 5.2% from 2023 to 2032.

Hemostat is referred to as a surgical agent that regulates and controls the bleeding process during surgical procedures. Hemostats help to shorten surgery time and reduce the need for blood transfusion. Hemostatic agents are essential in establishing hemostasis in pre-hospital conditions and preventing death associated with hemorrhage. Hemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used in adjunct to surgical procedures to manage bleeding. Hemostatic agents offer different benefits, which include decreased wound healing & operative time, better management of anti-coagulated patients, and reduction in the patient recovery period.

Global Hemostats Market Scope and Report Structure
Report Attribute Details
Market Size in 2022$3.4 bn
Market Size in 2032$5.9 bn
Growth Rate (2023-32)5.2%
Historic Period2016-2021
Forecast Period2023-2032
Base Year2022
Segments CoveredProduct Type, Formulation, Application, End-use, and Region
Key CompaniesTeleflex Incorporated, Baxter International, Inc., B. Braun Melsungen AG, Integra LifeSciences Corporation, Hemostasis, LLC, Ethicon (Johnson & Johnson), C.R. Bard (BD), Pfizer Inc., GELITA MEDICAL GmbH, Dalim Tissen, and Stryker Corp.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The growing demand for effective and efficient surgical and medical interventions is driven by an aging population and increasing instances of chronic diseases and traumatic injuries. As surgical procedures become more commonplace, there is a heightened emphasis on minimizing bleeding and improving patient outcomes, thereby escalating the need for advanced hemostatic products. Manufacturers are responding by developing innovative hemostats that offer quicker and more reliable hemostasis, reduced post-operative complications, and shorter recovery times. This trend is further supported by ongoing technological advancements in hemostatic agents, devices, and materials, all of which contribute to the expansion of the hemostat market.

The global hemostats market is positioned for substantial growth in the forthcoming years, primarily driven by the increasing number of surgical procedures conducted worldwide. As the global population continues to expand and age, there is a growing demand for surgical interventions to address various medical conditions. Surgeons and healthcare professionals are increasingly relying on hemostatic agents to effectively control bleeding during surgeries. Furthermore, advancements in surgical techniques and the rising prevalence of chronic diseases are leading to a higher frequency of surgical procedures, which is further boosting the demand for hemostats.

Market Restraints and Challenges

Increasing scrutiny and regulatory challenges associated with product safety and efficacy. As hemostats play a crucial role in controlling bleeding during surgical procedures, ensuring their reliability and minimizing adverse effects is paramount. Stringent regulatory requirements, evolving standards, and the need for rigorous clinical evidence can lead to extended approval timelines and heightened development costs for manufacturers. Additionally, concerns about potential side effects, such as tissue damage or allergic reactions, may dampen physician and patient confidence, impacting the adoption of new hemostat products in the market. These challenges underscore the necessity for thorough testing, transparent reporting, and continuous monitoring to meet regulatory demands and establish the safety and effectiveness of hemostatic solutions.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the hemostat market by generating both challenges and opportunities. While the pandemic led to disruptions in the global supply chain, limiting the availability of raw materials and hindering manufacturing processes, it also heightened the demand for hemostats in medical settings due to the surge in surgeries and treatments. The increased focus on infection prevention and the need to manage COVID-19-related complications have amplified the requirement for effective hemostatic products. As healthcare systems adapted to the crisis, telemedicine and remote patient monitoring gained prominence, influencing the distribution channels for hemostats. Despite initial setbacks, the market displayed resilience, adapting to the evolving healthcare landscape by incorporating technological advancements and novel distribution strategies.

Hemostats Market Segmental Overview

The Hemostats Market report is segmented on the basis of Product Type, Formulation, Application, End-use, and Region.

Hemostats Market, by Product Type

Based on Product Type, the Hemostats market has been segmented into Active Hemostats, Passive/Mechanical Hemostats, and Flowable Hemostats. Passive/Mechanical Hemostats further sub segmented into Oxidized Regenerated Cellulose-Based Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, and Polysaccharide Spheres Hemostats. The Passive/Mechanical Hemostats segment dominated the market during the forecast period. The demand for passive hemostats, such as gelatin, collagen, cellulose, and polysaccharide-based products, has been steadily increasing in the medical field. These mechanical hemostatic agents are gaining popularity for several reasons. Their ease of use and accessibility make them a preferred choice in various surgical settings. Mechanical hemostats, unlike some active biologic compounds, do not require special handling or refrigeration, making them convenient for healthcare providers in operating rooms. They can be readily applied as sponges to bleeding areas, providing a mechanical barrier to control bleeding and oozing effectively.

Hemostats Market, by Formulation

Based on Formulation, it is segmented into Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, and Powder Hemostats. The hemostats industry, by formulation, is dominated by the matrix and gel hemostats segment attributed to the advantages associated with these hemostats. Both hemostats quickly stop bleeding, lowering the possibility of severe blood loss during operations or other medical procedures. Moreover, using matrix and gel hemostats is frequently easier and faster than using sutures or other conventional techniques. This can help surgeons get more done in less time during operations. Further, using matrix and gel hemostats may eliminate the need for bigger incisions or more intrusive procedures, which may result in reduced scarring.

Hemostats Market, by Application

Based on Application, it is bifurcated into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. The Orthopedic Surgery segment dominated the market during the forecast period. The growing demand for orthopedic surgery applications in the hemostats market could be attributed to several factors, including an aging population with increased musculoskeletal issues, advancements in surgical techniques, and rising awareness of the importance of effective hemostasis in orthopedic procedures. Hemostats are crucial in controlling bleeding during surgeries, which is particularly significant in orthopedic surgeries involving bones and joints. As surgical technology advances, the demand for specialized hemostatic agents tailored for orthopedic procedures may continue to rise.

Hemostats Market, by End-use

On the basis of the End-use, the market is segmented into Ambulatory Surgical Centers, Hospitals, Clinics, and Community Healthcare. In 2022, the hospitals segment dominated the market. The demand for hospitals remains consistently high and continues to rise for multiple reasons. Ease of care in hospital applications involves making healthcare processes and procedures more convenient and efficient for healthcare providers and patients. Using effective hemostats during surgeries and procedures can help control bleeding quickly, leading to more efficient surgeries and potentially shorter hospital stays. Hospitals perform various surgeries and medical procedures, from routine to complex. Effective hemostasis is crucial in many of these procedures, driving the need for hospital hemostats.

Hemostats Market, by Region

Region-wise, it is studied across North America, Europe, Asia-Pacific, and the Rest of the World. North America held the largest market share accounting for nearly two-fifths share in 2022. The United States primarily dominates the North American hemostats market, responsible for more than three-quarters of the overall revenue produced in the area. The North American segment is expected to maintain its dominating position in the market during the projected period due to the prevalence of most surgeries performed yearly. According to the American Hospital Association, about 50 million surgical operations are conducted annually in the United States. This number encompasses various surgical treatments, from small outpatient surgeries to major surgery. As more surgeries are performed, more hemostats will be utilized during the surgeries, which drives the market growth.

Major Players in the Global Hemostats Market

The major players studied in the market are Baxter International Inc. (US), Ethicon (US), C.R. Bard (US), B. Braun Melsungen AG (Germany), Teleflex Incorporated (US), Integra Life Sciences (US), Hemostasis, LLC (US), Pfizer Inc. (US), Stryker (US), CyroLife Inc. (US), Dalim Tissen, and GELITA MEDICAL GmbH (Germany) among others. These major players operating in this market have adopted various strategies comprising M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launches.

Recent Developments
  • Recently in August 2023, Teleflex Incorporated, a global supplier of medical technologies, announced the Food and Drug Administration (FDA) has cleared the QuikClot Control+ Hemostatic Device for use in cardiac surgical procedures to control mild to moderate bleeding and bone surface hemorrhage after sternotomies. As a result, all bleeding during cardiac surgical operations may be controlled by doctors using the QuikClot Control+TM Device.
  • In May 2023, Premarket Application clearance for the PERCLOT Absorbable Hemostatic System to reduce bleeding in specific open and laparoscopic surgical procedures was announced by Artivion, Inc. In July 2021, Artivion sold Baxter International Inc. the PerClot product line. Following approval, Artivion will hand over control of the PMA to Baxter following the terms of its previously made public agreements with that company. After receiving a milestone payment of $18.75 million in cash, of which $4.5 million would go to Artivion’s previous partner, Starch Medical, Inc., the shipment of PerClot products to Baxter will start.
  • In October 2022, Pfizer Inc. has finalized its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical firm focused on developing transformative treatments, initially for sickle cell disease (SCD) and underserved patient populations. This acquisition strengthens Pfizer’s dedication to SCD and enhances its 30-year history in rare hematology.
  • In July 2021, Medcura, Inc., a medical company together with ASO LLC, announced the launch of a new class of antibacterial hemostatic gel, Rapid-Seal. This product meets the market demand for a transparent gel that will be easily applied to injuries.
  • In February 2021, EndoClot Plus, Inc., announced that the company had received clearance for EndoClot Polysaccharide Hemostatic system from the U.S. Food and Drug Administration (FDA). This innovative product helps gastroenterologists to prevent bleeding rapidly. This technology represents a significant milestone in advancing the care of the G.I. patient.
  • In March 2020, Institute of Nano Science and Technology, an autonomous institute under the Department of Science & Technology, developed a starch based ‘hemostat’ material. This material helps in stopping the blood flow by concentrating the natural clotting factors in the blood.
Hemostats Market Report Coverage
  • The report offers a comprehensive quantitative as well as qualitative analysis of the current Hemostats Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
  • The report also covers qualitative as well as quantitative analysis of Hemostats  Market in terms of revenue ($Million).
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hemostats Industry.
  • A thorough analysis of market trends and restraints is provided.
  • By region as well as country market analysis is also presented in this report.
  • Analytical depiction of the Hemostats Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hemostats industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, Market Share Analysis, and PESTLE analysis of the Hemostats Market are also analyzed.
Frequently Asked Questions

Q1. How big is the Hemostats Market?

Ans. The Hemostats Market size was USD 3.4 Billion in 2022 and is anticipated to reach USD 5.9 Billion in 2032, growing at a rate of 5.2% from 2023 to 2032.

Q2. What is the Hemostats Market growth rate?

Ans. The growth rate of the Hemostats Market is 5.2%.

Q3. Which region holds a major market share for the Hemostats Market?

Ans. North America held a significant Hemostats Market share in 2022.

Q4. Which segment accounted for the largest Hemostats Market share?

Ans. By product type, the passive hemostats segment accounted for the largest Hemostats Market revenue.

Q5. Who are the key players in the Hemostats Market?

Ans. Key players profiled in this report are Baxter International Inc. (US), Ethicon (US), C.R. Bard (US), B. Braun Melsungen AG (Germany), Teleflex Incorporated (US), Integra Life Sciences (US), Hemostasis, LLC (US), Pfizer Inc. (US), Stryker (US), CyroLife Inc. (US), Dalim Tissen, and GELITA MEDICAL GmbH (Germany) among others.

Q6. What are the factors driving the Hemostats Market growth?

Ans. The major factors driving the growth of the market are an increase in the number of surgical operations, developments in healthcare infrastructure, and an increase in aging population. Besides, market participants continued to engage in R&D activities, mergers, and acquisitions to produce more sophisticated hemostatic treatments.

Q7. What are the key growth strategies of Hemostats Market players?

Ans. The key growth strategies of Hemostats Market players are M&A, investment in R&D, collaborations, partnerships, regional business expansion, and new product launches.

Q8. Which region will provide more business opportunities for the Hemostats Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Hemostats Market during the forecast period.

Why GIS?

Table of Contents

Chapter 1. Hemostats Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Product Type
3.2. Market Attractiveness Analysis, by Formulation
3.3. Market Attractiveness Analysis, by Application
3.4. Market Attractiveness Analysis, by End-use
3.5. Market Attractiveness Analysis, by Region

Chapter 4. Hemostats Market Outlook
4.1. Hemostats Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Hemostats Market
4.7. Impact of the Russia and Ukraine War on the Hemostats Market
4.8. Case Study Analysis
4.9. Pricing Analysis
4.10 Hemostat Types and their Manufacturers List (Examples)

Chapter 5. Hemostats Market, by Product Type
5.3 Active Hemostats
5.3.1 Key Market Trends & Opportunity Analysis
5.3.2 Market Size and Forecast, by Region
5.4 Passive/Mechanical Hemostats
5.4.1 Key Market Trends & Opportunity Analysis
5.4.2 Market Size and Forecast, by Region
5.4.3 Market Size and Forecast, by Type
5.4.3.1 Oxidized Regenerated Cellulose-Based Hemostats
5.4.3.2 Gelatin Based Hemostats
5.4.3.3 Collagen Based Hemostats
5.4.3.4 Polysaccharide Spheres Hemostats
5.5 Flowable Hemostats
5.5.1 Key Market Trends & Opportunity Analysis
5.5.2 Market Size and Forecast, by Region

Chapter 6. Hemostats Market, by Formulation
6.1. Market Overview
6.2. Matrix & Gel Hemostats
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region
6.3. Sheet & Pad Hemostats
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region
6.4. Sponge Hemostats
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Size and Forecast, by Region
6.5. Powder Hemostats
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Size and Forecast, by Region

Chapter 7. Hemostats Market, by Application
7.1. Market Overview
7.2. Orthopedic Surgery
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region
7.3. General Surgery
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region
7.4. Neurological Surgery
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region
7.5. Cardiovascular Surgery
7.5.1. Key Market Trends & Opportunity Analysis
7.5.2. Market Size and Forecast, by Region
7.6. Reconstructive Surgery
7.6.1. Key Market Trends & Opportunity Analysis
7.6.2. Market Size and Forecast, by Region
7.7. Gynecological Surgery
7.7.1. Key Market Trends & Opportunity Analysis
7.7.2. Market Size and Forecast, by Region
7.8. Others
7.8.1. Key Market Trends & Opportunity Analysis
7.8.2. Market Size and Forecast, by Region

Chapter 8. Hemostats Market, by End-use
8.1. Market Overview
8.2. Ambulatory Surgical Centers
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. Market Size and Forecast, by Region
8.3. Clinics
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Market Size and Forecast, by Region
8.4. Community Healthcare
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Market Size and Forecast, by Region
8.5. Hospitals
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Market Size and Forecast, by Region

Chapter 9. Hemostats Market, by Region
9.1. Overview
9.2. North America
9.2.1. Key Market Trends and Opportunities
9.2.2. North America Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.3. North America Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.4. North America Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.5. North America Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.6. North America Hemostats Market Size and Forecast, by Country
9.2.7. The U.S.
9.2.7.1. The U.S. Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.7.2. The U.S. Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.7.3. The U.S. Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.7.4. The U.S. Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.8. Canada
9.2.8.1. Canada Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.8.2. Canada Hemostats Market Size and Forecast, by Formulation Concentrators
9.2.8.3. Canada Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.8.4. Canada Hemostats Market Size and Forecast, by End-use, 2022-2032
9.2.9. Mexico
9.2.9.1. Mexico Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.2.9.2. Mexico Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.2.9.3. Mexico Hemostats Market Size and Forecast, by Application, 2022-2032
9.2.9.4. Mexico Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3. Europe
9.3.1. Key Market Trends and Opportunities
9.3.2. Europe Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.3. Europe Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.4. Europe Hemostats Market Size and Forecast, by Application, 2022-2032, 2022-2032
9.3.5. Europe Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.6. Europe Hemostats Market Size and Forecast, by Country
9.3.7. The UK
9.3.7.1. The UK Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.7.2. The UK Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.7.3. The UK Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.7.4. The UK Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.8. Germany
9.3.8.1. Germany Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.8.2. Germany Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.8.3. Germany Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.8.4. Germany Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.9. France
9.3.9.1. France Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.9.2. France Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.9.3. France Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.9.4. France Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.10. Spain
9.3.10.1. Spain Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.10.2. Spain Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.10.3. Spain Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.10.4. Spain Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.11. Italy
9.3.11.1. Italy Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.11.2. Italy Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.11.3. Italy Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.11.4. Italy Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.12. Netherlands
9.3.12.1. Netherlands Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.12.2. Netherlands Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.12.3. Netherlands Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.12.4. Netherlands Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.13. Sweden
9.3.13.1. Sweden Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.13.2. Sweden Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.13.3. Sweden Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.13.4. Sweden Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.14. Switzerland
9.3.14.1. Switzerland Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.14.2. Switzerland Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.14.3. Switzerland Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.14.4. Switzerland Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.15. Denmark
9.3.15.1. Denmark Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.15.2. Denmark Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.15.3. Denmark Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.15.4. Denmark Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.16. Finland
9.3.16.1. Finland Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.16.2. Finland Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.16.3. Finland Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.16.4. Finland Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.17. Russia
9.3.17.1. Russia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.17.2. Russia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.17.3. Russia Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.17.4. Russia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.3.18. Rest of Europe
9.3.18.1. Rest of Europe Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.3.18.2. Rest of Europe Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.3.18.3. Rest of Europe Hemostats Market Size and Forecast, by Application, 2022-2032
9.3.18.4. Rest of Europe Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4. Asia-Pacific
9.4.1. Key Market Trends and Opportunities
9.4.2. Asia-Pacific Hemostats Market Size and Forecast, by Country
9.4.3. Asia-Pacific Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.4. Asia-Pacific Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.5. Asia-Pacific Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.6. Asia-Pacific Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.7. China
9.4.7.1. China Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.7.2. China Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.7.3. China Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.7.4. China Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.8. India
9.4.8.1. India Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.8.2. India Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.8.3. India Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.8.4. India Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.9. Japan
9.4.9.1. Japan Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.9.2. Japan Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.9.3. Japan Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.9.4. Japan Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.10. South Korea
9.4.10.1. South Korea Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.10.2. South Korea Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.10.3. South Korea Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.10.4. South Korea Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.11. Australia
9.4.11.1. Australia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.11.2. Australia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.11.3. Australia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.11.4. Australia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.12. Singapore
9.4.12.1. Singapore Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.12.2. Singapore Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.12.3. Singapore Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.12.4. Singapore Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.13. Indonesia
9.4.13.1. Indonesia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.13.2. Indonesia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.13.3. Indonesia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.13.4. Indonesia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.14. Taiwan
9.4.14.1. Taiwan Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.14.2. Taiwan Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.14.3. Taiwan Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.14.4. Taiwan Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.15. Malaysia
9.4.15.1. Malaysia Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.15.2. Malaysia Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.15.3. Malaysia Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.15.4. Malaysia Hemostats Market Size and Forecast, by End-use, 2022-2032
9.4.16. Rest of APAC
9.4.16.1. Rest of APAC Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.4.16.2. Rest of APAC Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.4.16.3. Rest of APAC Hemostats Market Size and Forecast, by Application, 2022-2032
9.4.16.4. Rest of APAC Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5. Rest of The World
9.5.1. Key Market Trends and Opportunities
9.5.2. Rest of The World Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.3. Rest of The World Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.4. Rest of The World Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.5. Rest of The World Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.6. Rest of The World Hemostats Market Size and Forecast, by Country
9.5.7. Latin America
9.5.7.1. Latin America Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.7.2. Latin America Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.7.3. Latin America Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.7.4. Latin America Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.8. Middle East
9.5.8.1. Middle East Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.8.2. Middle East Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.8.3. Middle East Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.8.4. Middle East Hemostats Market Size and Forecast, by End-use, 2022-2032
9.5.9. Africa
9.5.9.1. Africa Hemostats Market Size and Forecast, by Product Type, 2022-2032
9.5.9.2. Africa Hemostats Market Size and Forecast, by Formulation, 2022-2032
9.5.9.3. Africa Hemostats Market Size and Forecast, by Application, 2022-2032
9.5.9.4. Africa Hemostats Market Size and Forecast, by End-use, 2022-2032

Chapter 10. Competitive Landscape
10.1. Overview
10.2. Market Share Analysis
10.2.1 North America Market Share Analysis, by Active Hemostats
10.2.2 North America Market Share Analysis, by Passive Hemostats
10.2.3 North America Market Share Analysis, by Flowable Hemostats
10.2.4 Europe Market Share Analysis, by Active Hemostats
10.2.5 Europe Market Share Analysis, by Passive Hemostats
10.2.6 Europe Market Share Analysis, by Flowable Hemostats
10.2.7 Asia-Pacific Market Share Analysis, by Active Hemostats
10.2.8 Asia-Pacific Market Share Analysis, by Passive Hemostats
10.2.9 Asia-Pacific Market Share Analysis, by Flowable Hemostats
10.2.10 Rest of the World Market Share Analysis, by Active Hemostats
10.2.11 Rest of the World Market Share Analysis, by Passive Hemostats
10.2.12 Rest of the World Market Share Analysis, by Flowable Hemostats
10.3. Vendor Benchmarking
10.4. Developmental Strategy Benchmarking
10.4.1. New Product Developments
10.4.2. Product Launches
10.4.3. Business Expansions
10.4.4. Partnerships, Joint Ventures, and Collaborations
10.4.5. Mergers and Acquisitions

Chapter 11. Company Profiles
11.1. Baxter International Inc. (US)
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Offerings
11.1.4. Key Developmental Strategies
11.1.5. SWOT Analysis
11.2. B. Braun Melsungen AG (Germany)
11.2.1. Company Snapshot
11.2.2. Financial Performance
11.2.3. Product Offerings
11.2.4. Key Developmental Strategies
11.2.5. SWOT Analysis
11.3. Integra Life Sciences (US)
11.3.1. Company Snapshot
11.3.2. Financial Performance
11.3.3. Product Offerings
11.3.4. Key Developmental Strategies
11.3.5. SWOT Analysis
11.4. Hemostasis, LLC (US)
11.4.1. Company Snapshot
11.4.2. Financial Performance
11.4.3. Product Offerings
11.4.4. Key Developmental Strategies
11.4.5. SWOT Analysis
11.5. Ethicon (US)
11.5.1. Company Snapshot
11.5.2. Financial Performance
11.5.3. Product Offerings
11.5.4. Key Developmental Strategies
11.5.5. SWOT Analysis
11.6. C.R. Bard (US)
11.6.1. Company Snapshot
11.6.2. Financial Performance
11.6.3. Product Offerings
11.6.4. Key Developmental Strategies
11.6.5. SWOT Analysis
11.7. Pfizer Inc. (US)
11.7.1. Company Snapshot
11.7.2. Financial Performance
11.7.3. Product Offerings
11.7.4. Key Developmental Strategies
11.7.5. SWOT Analysis
11.8. Stryker (US)
11.8.1. Company Snapshot
11.8.2. Financial Performance
11.8.3. Product Offerings
11.8.4. Key Developmental Strategies
11.8.5. SWOT Analysis
11.9. Teleflex Incorporated (US)
11.9.1. Company Snapshot
11.9.2. Financial Performance
11.9.3. Product Offerings
11.9.4. Key Developmental Strategies
11.9.5. SWOT Analysis
11.10. GELITA MEDICAL GmbH (Germany)
11.10.1. Company Snapshot
11.10.2. Financial Performance
11.10.3. Product Offerings
11.10.4. Key Developmental Strategies
11.10.5. SWOT Analysis
11.11. Dalim Tissen
11.11.1. Company Snapshot
11.11.2. Financial Performance
11.11.3. Product Offerings
11.11.4. Key Developmental Strategies
11.11.5. SWOT Analysis

*The list of companies is subject to change during the final compilation of the report

Global Hemostat Market Segmentation

By Product Type

  • Flowable Hemostats
  • Active Hemostats
  • Passive Hemostats
    • Oxidized Regenerated Cellulose-Based Hemostats
    • Gelatin Based Hemostats
    • Collagen Based Hemostats
    • Polysaccharide Spheres Hemostats

By Formulation

  • Matrix & Gel Hemostats
  • Sheet & Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

By End-use

  • Ambulatory Surgical Centers
  • Clinics
  • Community Healthcare
  • Hospitals

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Netherlands
    • Sweden
    • Switzerland
    • Denmark
    • Finland
    • Russia
    • Rest of Europe
  • The Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Indonesia
    • Taiwan
    • Malaysia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Lasers are intense beams of light that can…
Drug safety is the process of ensuring that…
Intubation tubes, also referred to as endotracheal tubes,…
Wound healing films are a type of wound…
Blood Temperature Indicator market was valued at USD…
Automated Sample Storage Systems are systems designed to…
Medical Transport Boxes are highly specialized containers specifically…
The Precision Diagnostics market size was USD 45.6…
Ultrasound Needle Guides are devices designed to help…
The global wearable healthcare devices market was valued…